阴道内装置治疗女性跑步诱发性尿失禁症状:一项研究方案
本方案为评估者盲法随机对照试验,计划招募90名≥18岁、有跑步诱发性尿失禁且具女性典型盆腔解剖的跑步者,先进行2周无干预漏尿追踪,再按1:1:1随机分配至10周子宫托、卫生棉条或对照干预,主要结局包括跑步期间漏尿频率与量、患者整体改善印象、治疗满意度及ICIQ-UI简表,随访评估在第11-12周和16周进行。
要点
- 评估者盲法随机对照试验,比较子宫托、卫生棉条与对照干预对跑步诱发性尿失禁的效果。
- 主要结局为2周跑步期间漏尿频率与量、PGI-I、治疗满意度及ICIQ-UI简表。
- 计划招募90名≥18岁有跑步诱发性尿失禁且具女性典型盆腔解剖的跑步者。
核心结论
- 支持盆腔结构的阴道内装置可能提供解决方案,但缺乏高质量证据。
研究设计与样本
- 评估者盲法随机对照试验,计划招募90名跑步者,按1:1:1随机分配至10周子宫托、卫生棉条或对照干预。
主要发现
- 原文未报告结果。
关键数值与推荐
- 主要结局在基线和10周干预后测量:2周跑步期间漏尿频率与量、患者整体改善印象、治疗满意度、ICIQ-UI简表。
- 次要结局包括依从性和非预期效应。
- 部分参与者受邀在基线和随访时进行实验室评估,包括盆底形态测量和功能检查。
- 随访评估在第11-12周和16周进行。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Exercise-induced urinary incontinence (UI) can hinder physical activity, particularly in women engaging in high-impact activities. This condition is linked to reduced passive support of the urethra and bladder. Intravaginal devices that support pelvic structures may offer a solution, but high-quality evidence is lacking. STUDY DESIGN: The study is an assessor-blind randomised controlled trial. PRIMARY AND SECONDARY ENDPOINTS: Primary outcomes include frequency and amount of urine leakage during running over a 2-week period, Patient Global Impression of Improvement, treatment satisfaction, and the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form, measured at baseline and after a 10-week intervention. Secondary outcomes include adherence and unintended effects. A subset of participants will be invited to a laboratory-based assessment at baseline and follow-up involving pelvic floor morphometry and function to explore the mechanisms through which the interventions may be effective. PATIENTS AND METHODS: We aim to recruit 90 runners aged ≥18 years, with female-typical pelvic anatomy, who report running-induced UI. After 2 weeks of leakage tracking without any intervention, participants will be randomly assigned to a 10-week pessary, tampon, or control intervention (1:1:1 ratio). Follow-up assessments will be performed at 11-12 and 16 weeks. Between- and within-group differences will be evaluated with general linear models using an intent-to-treat approach. TRIAL REGISTRATION AND ETHICS: This study is registered (ClinicalTrials.gov identifier: NCT05773378), has been approved by the local Institutional Research Ethics Board, and follows the Declaration of Helsinki. Results will be published in peer-reviewed journals, shared with clinicians and participants, and disseminated publicly.
引用
- Vesting S, Petter Rodrigues M, Collins G, et al. Intravaginal devices for running-induced urinary incontinence symptoms in females: a study protocol. BJU Int. 2025. PMID: 40071535. doi:10.1111/bju.16708
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。